Mind.PX
Mindera Health™ announces first patient enrolled in the MATCH Study: a clinical utility evaluation of the impact of Mind.Px™ on response rates of psoriasis patients who are prescribed biologics
21 oct. 2021 12h00 HE | Mindera Health
San Diego, CA, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Mindera Health, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,...
researchdrivelogo.jpg
Emerging Trends: Dermacosmetics Market to Experience Substantial Growth Due to Rising Demand for Skin Care Products across the Globe – Exclusive Report [348 Pages] By Research Dive
20 oct. 2021 09h00 HE | Research Dive
New York, USA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- A new report on the global dermacosmetics market has been added by Research Dive to its repository. According to the report, the global market is...
RAD_2021_Logo
The Foundation for Dermatology Education to Host the 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference - Saturday, December 11 - Monday, December 13, 2021
19 oct. 2021 10h00 HE | The Foundation for Dermatology Education
CHICAGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- The 3rd Annual Live Revolutionizing Atopic Dermatitis (RAD) Conference will be held virtually this year from Saturday, December 11 - Monday, December 13...
Colorescience Total Eye Firm & Repair Cream
COLORESCIENCE® ADDS NEW INNOVATION TO AWARD-WINNING TOTAL EYE® COLLECTION
18 oct. 2021 08h45 HE | Colorescience
Carlsbad, CA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colorescience®, a leading dermatologist-recommended skincare company, announces the launch of Total Eye® Firm & Repair Cream, a highly-sought...
22157.jpg
Global Dermal Fillers Market Forecast (2021 to 2028) - COVID-19 Impact and Analysis
12 oct. 2021 07h18 HE | Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Global Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biodegradable, and Non-Biodegradable); Material;...
TIP_link_300x300.jpg
Dermal Fillers Market Size to Outstrip $9,421.33Mn by 2028 Growth Projections at 11.5% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
06 oct. 2021 08h05 HE | The Insight Partners
New York, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Dermal Fillers Market: Key InsightsAccording to our new research study on “Dermal Fillers Market to 2028 – Global Analysis and Forecast – by Product,...
Mindera Corporation
Mindera Corporation Shifts Name to Mindera Health to Sharpen Focus on Its Personalized Medicine Platform
05 oct. 2021 11h00 HE | Mindera Health
San Diego, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Mindera Corporation, developers of the groundbreaking Mind.Px™ - the first realization of truly personalized medicine in psoriasis - has changed its...
Lanier Standard-logo-color.jpg
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
05 oct. 2021 08h00 HE | Lanier Biotherapeutics
BOGART, Ga., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, and Type 2...
Arcutis logo.png
New Data Highlighting Itch Reduction with Topical Roflumilast in Multiple Dermatologic Conditions Presented at European Academy of Dermatology and Venereology Congress
30 sept. 2021 08h30 HE | Arcutis Biotherapeutics, Inc.
Topical roflumilast provided significant improvements in severity and burden of itch in Phase 3 plaque psoriasis studies, as well as Phase 2 studies in seborrheic dermatitis and scalp and body...
Arcutis logo.png
New Topical Roflumilast Data Presented at the European Academy of Dermatology and Venereology (EADV) Congress
27 sept. 2021 08h05 HE | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations in...